Abstract
Percutaneous transluminal angioplasty has become widely spread as the initial treatment in patients with iliac occlusive disease. Although not confirmed by the current TransAtlantic Inter-Society Consensus (TASC) II recommendations, endovascular repair of complex aortoiliac lesions is feasible and gives similar angiographic and clinical outcome compared with open surgery at both short- and long-term follow-up, even in complex lesion configurations. Besides the commonly accepted TASC A and B lesions, TASC C and D lesions could also be treated endovasculary with the current devices, techniques and modalities. This opens new perspectives for a group of patients presenting with severe comorbidities.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call